Quartuccio, Luca
 Distribuzione geografica
Continente #
AS - Asia 246
EU - Europa 171
NA - Nord America 107
SA - Sud America 31
AF - Africa 7
OC - Oceania 2
Totale 564
Nazione #
SG - Singapore 115
US - Stati Uniti d'America 105
HK - Hong Kong 68
RU - Federazione Russa 35
DE - Germania 31
IT - Italia 31
BR - Brasile 29
FI - Finlandia 27
TR - Turchia 21
CN - Cina 19
NL - Olanda 8
AT - Austria 7
PL - Polonia 7
IE - Irlanda 5
PK - Pakistan 5
GB - Regno Unito 4
MA - Marocco 4
AZ - Azerbaigian 3
CZ - Repubblica Ceca 3
EG - Egitto 3
AU - Australia 2
CH - Svizzera 2
JO - Giordania 2
MX - Messico 2
PE - Perù 2
PH - Filippine 2
SA - Arabia Saudita 2
UA - Ucraina 2
AM - Armenia 1
BD - Bangladesh 1
BE - Belgio 1
DK - Danimarca 1
EE - Estonia 1
ES - Italia 1
FR - Francia 1
GE - Georgia 1
ID - Indonesia 1
IL - Israele 1
JP - Giappone 1
KG - Kirghizistan 1
KH - Cambogia 1
LU - Lussemburgo 1
LV - Lettonia 1
PT - Portogallo 1
SE - Svezia 1
UZ - Uzbekistan 1
Totale 564
Città #
Hong Kong 68
Singapore 60
Helsinki 23
Istanbul 20
Munich 11
Romola 11
Beijing 10
Moscow 10
New York 7
Nuremberg 7
Warsaw 6
Ashburn 5
Dublin 5
Milan 5
Shanghai 5
The Dalles 5
Brooklyn 4
Faisalabad 4
Lappeenranta 4
São Paulo 4
Baku 3
Brno 3
Cairo 3
Curitiba 3
Pescara 3
Amman 2
Falkenstein 2
Frankfurt am Main 2
Newark 2
Osasco 2
Quezon City 2
Rabat 2
Vienna 2
Zurich 2
Amsterdam 1
Arapiraca 1
Atlanta 1
Bishkek 1
Blumenau 1
Boston 1
Brussels 1
Cabreúva 1
Campinas 1
Campos de Júlio 1
Cincinnati 1
Coimbra 1
Cornélio Procópio 1
Dhaka 1
Dois Vizinhos 1
Fortaleza 1
Ganzhou 1
Garça 1
Guangzhou 1
Hortolândia 1
Islamabad 1
Jardinópolis 1
Jeddah 1
Kilburn 1
Lima 1
Los Angeles 1
Luxembourg 1
Madrid 1
Mexico City 1
Monte Castelo 1
Naples 1
Nova Friburgo 1
Nova Iguaçu 1
Nova Lima 1
Odunpazari 1
Palmares do Sul 1
Panelas 1
Petriolo 1
Phnom Penh 1
Riga 1
Riyadh 1
Rome 1
Salé 1
San Francisco 1
Santa Clara 1
Sepino 1
Simferopol 1
Stockholm 1
São José do Rio Preto 1
São Lourenço do Oeste 1
Tallinn 1
Tashkent 1
Tbilisi 1
Tel Aviv 1
Tokyo 1
Yerevan 1
Totale 363
Nome #
Vaccine hesitancy decreases, long term concerns remain in myositis, rheumatic disease patients: A comparative analysis of the COVAD surveys 49
COVID-19 vaccination in autoimmune diseases (COVAD) Study: vaccine safety and tolerance in rheumatoid arthritis 37
COVID-19 vaccine safety during the antenatal period in women with idiopathic inflammatory myopathies 35
Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study 32
Characteristics of emerging new autoimmune diseases after COVID-19 vaccination: A sub-study by the COVAD group 32
Global disparities in the treatment of idiopathic inflammatory myopathies: results from an international online survey study 30
COVAD survey 2 long-term outcomes: unmet need and protocol 30
Breakthrough SARS-CoV-2 infection and disease flares in patients with rheumatoid arthritis: result from COVAD e-survey study 28
Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey 27
Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period-a cross-sequential study based on COVAD surveys 27
COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD study 27
High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey 25
COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group 25
Breakthrough SARS‑CoV‑2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID‑19 Vaccination in Autoimmune Disease (COVAD) study 22
Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveys 22
Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study 22
Impaired physical function in patients with idiopathic inflammatory myopathies: results from the multicentre COVAD patient-reported e-survey 21
COVID-19 severity, breakthrough infections and vaccine safety in young individuals with autoimmune diseases: insights from the COVAD study 20
COVID-19 vaccination-related adverse events among autoimmune disease patients: results from the COVAD study 19
Diagnostic pathway and treatment preferences for systemic lupus erythematosus: a physician-based discrete choice experiment 18
COVID-19 vaccination-related delayed adverse events among people with rheumatoid arthritis: results from the international COVAD survey 18
Preferences for diagnostic pathways and treatment choice in systemic lupus erythematosus: a patient-based discrete choice experiment 15
Self-Reported Delayed Adverse Events and Flare Following COVID-19 Vaccination Among Patients With Autoimmune Rheumatic Disease (AIRD) in Malaysia: Results From the COVAD-2 Study 7
Totale 588
Categoria #
all - tutte 4.856
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.856


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202324 0 0 0 0 0 13 0 1 2 0 3 5
2023/2024133 3 5 11 12 2 14 4 1 29 3 5 44
2024/2025431 7 20 17 45 24 48 73 67 41 35 54 0
Totale 588